AbbVie Operating Income from 2010 to 2026

ABBV Stock

USD 236.19 2.33 1.00%

AbbVie Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about 10.6 B in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit AbbVie Inc generates from its operations. View All Fundamentals

Operating Income

First Reported

2010-12-31

Previous Quarter

1.9 B

Current Value

5.8 B

Quarterly Volatility

1.6 B

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 20 B, Interest Expense of 1.4 B or Selling General Administrative of 8 B, as well as many indicators such as Price To Sales Ratio of 3.57, Dividend Yield of 0.0283 or Days Sales Outstanding of 79.82. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.

Build AI portfolio with AbbVie Stock

Check out the analysis of AbbVie Correlation against competitors.

The evolution of Operating Income for AbbVie Inc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how AbbVie compares to historical norms and industry peers.

Latest AbbVie's Operating Income Growth Pattern

Below is the plot of the Operating Income of AbbVie Inc over the last few years. Operating Income is the amount of profit realized from AbbVie Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of AbbVie Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. AbbVie's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

AbbVie Operating Income Regression Statistics

	Arithmetic Mean	10,022,669,105
	Geometric Mean	8,775,157,771
	Coefficient Of Variation	52.31
	Mean Deviation	4,098,929,065
	Median	9,340,000,000
	Standard Deviation	5,243,031,851
	Sample Variance	27489383T
	Range	17.8B
	R-Value	0.76
	Mean Square Error	12412752.7T
	R-Squared	0.58
	Significance	0.0004
	Slope	788,456,604
	Total Sum of Squares	439830127.9T

AbbVie Operating Income History

	2026	10.6 B
	2025	21.2 B
	2024	9.1 B
	2023	12.8 B
	2022	18.1 B
	2021	17.9 B
	2020	11.4 B

Other Fundumenentals of AbbVie Inc

Non Operating Income Net Other

AbbVie Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Intangible Assets	Property Plant Equipment	Long Term Debt	Short Term Debt	Common Stock	Net Tangible Assets	Retained Earnings	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Treasury Stock	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Current Deferred Revenue
Total Assets		0.17	0.97	0.91	0.92	0.98	-0.44	0.99	0.67	0.97	0.96	0.95	0.82	-0.53	-0.97	-0.29	0.95	0.88	0.42	-0.04	-0.1	0.67	0.87	-0.45	-0.16	0.27
Total Stockholder Equity	0.17		0.11	0.06	0.16	0.16	-0.13	0.02	-0.29	0.33	0.23	-0.05	0.04	0.39	-0.13	0.33	-0.02	-0.14	0.04	-0.21	0.67	0.19	0.38	-0.21	0.37	-0.38
Net Debt	0.97	0.11		0.86	0.87	0.96	-0.34	0.96	0.55	0.97	0.93	0.94	0.84	-0.57	-0.96	-0.31	0.92	0.87	0.5	0.05	-0.11	0.68	0.83	-0.53	-0.17	0.29
Accounts Payable	0.91	0.06	0.86		0.95	0.94	-0.48	0.91	0.6	0.84	0.93	0.8	0.79	-0.59	-0.87	-0.44	0.84	0.91	0.37	-0.06	-0.07	0.61	0.7	-0.56	-0.23	0.4
Net Receivables	0.92	0.16	0.87	0.95		0.96	-0.42	0.91	0.56	0.87	0.97	0.8	0.74	-0.44	-0.87	-0.49	0.83	0.81	0.26	-0.17	0.05	0.65	0.77	-0.61	-0.26	0.44
Good Will	0.98	0.16	0.96	0.94	0.96		-0.43	0.97	0.58	0.96	0.98	0.89	0.8	-0.49	-0.96	-0.39	0.91	0.88	0.42	-0.03	-0.06	0.67	0.82	-0.57	-0.2	0.35
Short Term Investments	-0.44	-0.13	-0.34	-0.48	-0.42	-0.43		-0.42	-0.39	-0.39	-0.46	-0.38	-0.43	0.15	0.43	0.27	-0.49	-0.47	-0.02	0.35	-0.01	-0.37	-0.47	0.16	0.19	-0.2
Total Liab	0.99	0.02	0.96	0.91	0.91	0.97	-0.42		0.73	0.93	0.94	0.97	0.83	-0.6	-0.96	-0.33	0.96	0.91	0.42	0.0	-0.22	0.65	0.82	-0.41	-0.18	0.31
Total Current Assets	0.67	-0.29	0.55	0.6	0.56	0.58	-0.39	0.73		0.49	0.54	0.78	0.52	-0.58	-0.59	-0.12	0.77	0.66	0.13	-0.13	-0.49	0.34	0.53	0.21	-0.13	0.18
Intangible Assets	0.97	0.33	0.97	0.84	0.87	0.96	-0.39	0.93	0.49		0.93	0.89	0.8	-0.46	-0.97	-0.22	0.89	0.81	0.48	0.0	0.02	0.68	0.9	-0.54	-0.11	0.18
Property Plant Equipment	0.96	0.23	0.93	0.93	0.97	0.98	-0.46	0.94	0.54	0.93		0.85	0.82	-0.42	-0.91	-0.41	0.89	0.83	0.29	-0.17	0.07	0.73	0.85	-0.59	-0.19	0.38
Long Term Debt	0.95	-0.05	0.94	0.8	0.8	0.89	-0.38	0.97	0.78	0.89	0.85		0.76	-0.65	-0.93	-0.22	0.97	0.86	0.48	0.01	-0.32	0.56	0.81	-0.25	-0.16	0.23
Short Term Debt	0.82	0.04	0.84	0.79	0.74	0.8	-0.43	0.83	0.52	0.8	0.82	0.76		-0.53	-0.82	-0.29	0.8	0.8	0.23	0.03	-0.1	0.9	0.72	-0.49	-0.18	0.29
Common Stock	-0.53	0.39	-0.57	-0.59	-0.44	-0.49	0.15	-0.6	-0.58	-0.46	-0.42	-0.65	-0.53		0.53	0.12	-0.56	-0.69	-0.46	-0.25	0.38	-0.21	-0.32	0.15	0.14	-0.15
Net Tangible Assets	-0.97	-0.13	-0.96	-0.87	-0.87	-0.96	0.43	-0.96	-0.59	-0.97	-0.91	-0.93	-0.82	0.53		0.34	-0.93	-0.87	-0.48	-0.03	0.13	-0.68	-0.88	0.53	0.28	-0.28
Retained Earnings	-0.29	0.33	-0.31	-0.44	-0.49	-0.39	0.27	-0.33	-0.12	-0.22	-0.41	-0.22	-0.29	0.12	0.34		-0.32	-0.35	-0.03	0.25	-0.19	-0.34	-0.28	0.66	0.82	-0.85
Long Term Debt Total	0.95	-0.02	0.92	0.84	0.83	0.91	-0.49	0.96	0.77	0.89	0.89	0.97	0.8	-0.56	-0.93	-0.32		0.89	0.4	-0.08	-0.24	0.6	0.84	-0.29	-0.23	0.32
Capital Surpluse	0.88	-0.14	0.87	0.91	0.81	0.88	-0.47	0.91	0.66	0.81	0.83	0.86	0.8	-0.69	-0.87	-0.35	0.89		0.51	0.15	-0.34	0.5	0.63	-0.4	-0.25	0.37
Deferred Long Term Liab	0.42	0.04	0.5	0.37	0.26	0.42	-0.02	0.42	0.13	0.48	0.29	0.48	0.23	-0.46	-0.48	-0.03	0.4	0.51		0.43	-0.2	-0.05	0.27	-0.21	-0.12	0.1
Long Term Investments	-0.04	-0.21	0.05	-0.06	-0.17	-0.03	0.35	0.0	-0.13	0.0	-0.17	0.01	0.03	-0.25	-0.03	0.25	-0.08	0.15	0.43		-0.48	-0.13	-0.31	-0.01	0.05	-0.08
Treasury Stock	-0.1	0.67	-0.11	-0.07	0.05	-0.06	-0.01	-0.22	-0.49	0.02	0.07	-0.32	-0.1	0.38	0.13	-0.19	-0.24	-0.34	-0.2	-0.48		0.15	0.21	-0.43	-0.04	0.04
Short Long Term Debt	0.67	0.19	0.68	0.61	0.65	0.67	-0.37	0.65	0.34	0.68	0.73	0.56	0.9	-0.21	-0.68	-0.34	0.6	0.5	-0.05	-0.13	0.15		0.7	-0.54	-0.21	0.3
Net Invested Capital	0.87	0.38	0.83	0.7	0.77	0.82	-0.47	0.82	0.53	0.9	0.85	0.81	0.72	-0.32	-0.88	-0.28	0.84	0.63	0.27	-0.31	0.21	0.7		-0.42	-0.23	0.18
Net Working Capital	-0.45	-0.21	-0.53	-0.56	-0.61	-0.57	0.16	-0.41	0.21	-0.54	-0.59	-0.25	-0.49	0.15	0.53	0.66	-0.29	-0.4	-0.21	-0.01	-0.43	-0.54	-0.42		0.46	-0.48
Capital Stock	-0.16	0.37	-0.17	-0.23	-0.26	-0.2	0.19	-0.18	-0.13	-0.11	-0.19	-0.16	-0.18	0.14	0.28	0.82	-0.23	-0.25	-0.12	0.05	-0.04	-0.21	-0.23	0.46		-0.8
Current Deferred Revenue	0.27	-0.38	0.29	0.4	0.44	0.35	-0.2	0.31	0.18	0.18	0.38	0.23	0.29	-0.15	-0.28	-0.85	0.32	0.37	0.1	-0.08	0.04	0.3	0.18	-0.48	-0.8

Click cells to compare fundamentals

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	21.2 B	10.6 B
Non Operating Income Net Other	-2.3 B	-2.5 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

AbbVie Operating Income from 2010 to 2026

Latest AbbVie's Operating Income Growth Pattern

AbbVie Operating Income Regression Statistics

AbbVie Operating Income History

Other Fundumenentals of AbbVie Inc

AbbVie Operating Income component correlations

About AbbVie Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for AbbVie Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY